A recent article examined the future of pathology and lab medicine, focusing on the importance of humanoid technology and digital pathology. It also highlighted the impact of disruptive innovations on the field, and the need for more direct patient consultation. To get a deeper understanding of the future of pathology and lab medicine, read the full article. We’ll also explore the role of pathologists in defining the implications of laboratory findings.
Digital pathology
The rapid development of information technology has facilitated the adoption of digital pathology (DP) as a diagnostic practice. Early personal computers made use of digital pathology, and the concept has gradually been accepted in clinical settings. Today, multi-site medical centers and health organizations with different geographic locations are recognizing DP as a standard diagnostic procedure. The use of quantum biocomputing and quad-core processing is likely to change the face of academic institutions and colleges in the third decade.
The benefits of digital pathology are numerous. Digital pathology images are stored on secure servers, enabling pathologists to consult them remotely and collaborate on cases from any location. Although digital pathology has numerous advantages, widespread adoption is still limited and deployment projections for primary diagnostic use are modest. Nevertheless, digital pathology has enormous potential to meet the challenges of increasing demand and reducing workforce capacity. Let’s look at the benefits and risks of digital pathology.
Humanoid technology
Artificial intelligence (AI) algorithms will be crucial in diagnosing diseases and making complex treatment plans, but incorporating AI into the workflow of pathology is expensive and difficult. But as the field of pathology undergoes change and advances, AI-enabled tools will play an increasingly important role. While AI-based systems are not likely to replace human pathologists, they will improve the diagnostic process and save money, while reducing human and infrastructural resource demands.
AI-powered machines can revolutionize the field of pathology. AI can ensure rapid results, enabling pathologists to focus on higher-level diagnostic tasks. In addition, AI can integrate morphologic, molecular, and clinical information to determine a patient’s prognosis objectively. These technologies can help patients receive faster diagnoses and better treatment. They can also be utilized for medical research and education.
Impact of disruptive innovations
In his recent paper, Cody Carter, chief resident of the Department of Pathology, discusses disruptive innovations in histology and digital pathology. In his piece, Carter highlights new opportunities in diagnostics in Sub-Saharan Africa. The impact of these technologies on pathology will have significant impacts on the future of patient care. This article is an excerpt from his article in the quarterly journal of the American Society for Clinical Pathology.
Disruptive innovations in pathology and laboratory medicine will bring new benchmarks and value propositions to patients. They will transform the way laboratory medicine is delivered and enable improved access to health care for all. These technologies will help to improve care in low-resource settings and in developing nations. Disruptive innovations will make pathology and lab medicine accessible to patients worldwide. But before any disruptive innovation can achieve these benefits, it must pass regulatory hurdles.
Need for more direct consultation with patients
The growing use of electronic health records (EHRs) and decentralized health systems has made it difficult for primary care physicians to consult with laboratory professionals. A recent study found that only six percent of primary care physicians consulted with lab professionals each week. This decrease in direct patient consultation indicates that the EHR system has changed interphysican communication patterns. More direct patient consultations may help to improve the patient experience.
In an era of health-care reform and cost-control, the relationship between clinicians and pathologists is increasingly important. Pathologists have a unique perspective on disease progression, which makes them uniquely suited to provide guidance to their clinical colleagues. They can recommend the appropriate tests to order and interpret results, as well as follow-up testing. Additionally, they can advise their clinical colleagues about which laboratory tests to send out and when to order them. These insights can influence the quality of care, speed, and cost of care.This Article is shared by morain khan – working as a content writer in digital marketing company in Jaipur.
